Bone cancer pain

Juan Miguel Jimenez-Andrade, William G. Mantyh, Aaron P. Bloom, Alice S. Ferng, Christopher P. Geffre, Patrick W. Mantyh

Research output: Chapter in Book/Report/Conference proceedingConference contribution

154 Scopus citations

Abstract

In the United States, cancer is the second most common cause of death and it is expected that about 562,340 Americans will have died of cancer in 2009. Bone cancer pain is common in patients with advanced breast, prostate, and lung cancer as these tumors have a remarkable affinity to metastasize to bone. Once tumors metastasize to bone, they are a major cause of morbidity and mortality as the tumor induces significant skeletal remodeling, fractures, pain, and anemia. Currently, the factors that drive cancer pain are poorly understood. However, several recently introduced models of bone cancer pain, which closely mirror the human condition, are providing insight into the mechanisms that drive bone cancer pain and guide the development of mechanism-based therapies to treat the cancer pain. Several of these mechanism-based therapies have now entered human clinical trials. If successful, these therapies have the potential to significantly enlarge the repertoire of modalities that can be used to treat bone cancer pain and improve the quality of life, functional status, and survival of patients with bone cancer.

Original languageEnglish (US)
Title of host publicationNeurons and Networks in the Spinal Cord
PublisherBlackwell Publishing Inc
Pages173-181
Number of pages9
ISBN (Print)9781573317788
DOIs
StatePublished - Jun 2010
Externally publishedYes

Publication series

NameAnnals of the New York Academy of Sciences
Volume1198
ISSN (Print)0077-8923
ISSN (Electronic)1749-6632

Keywords

  • osteosarcoma
  • prostate
  • therapies

Fingerprint

Dive into the research topics of 'Bone cancer pain'. Together they form a unique fingerprint.

Cite this